Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial

Indian Journal of Dermatology, Venereology and Leprology

Volumn 77, Issue 6, 2011, Pages 688-694

  Agarwal, Uma Shankar ^a   Besarwal, Raj Kumar ^a   Bhola, Kalyani ^a  

^a SMS MEDICAL COLLEGE   (India)

Author keywords

Acne; isotretinoin; low dose

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN PHOSPHATE; ISOTRETINOIN;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTHRALGIA; ARTICLE; BONE PAIN; CHEILITIS; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; DRY EYE; DRY NOSE; DRY SKIN; EPISTAXIS; FATIGUE; FEMALE; FOLLOW UP; HAIR LOSS; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MUSCULAR CRAMPS; PHOTOSENSITIVITY; RANDOMIZED CONTROLLED TRIAL; RASH; RELAPSE; XEROSTOMIA;

ACNE VULGARIS; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOTRETINOIN; MALE; RECURRENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80155213743     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.86482     Document Type: Article

References (24)

1. Dreno B, Poli F. Epidemiology of acne. Dermatology 2003;43:1042-8.
2. Kaymak Y, Ilter N. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne. J Eur Acad Dermatol Venereol 2006;20:1256-60. (Pubitemid 44614625)
3. Harper JC, Thibutot DM. Pathogenesis of acne: Recent research advances. Adv Dermatol 2003;19:1-10. (Pubitemid 39297508)
4. Cunliffe W, Gollnick H. Acne. In: Arndt KA, LeBoit PE, Robinson JK, Wintroub BU, editors. Cutaneous Medicine and Surgery. Philadelphia, Pa: WB Saunders Co; 1996. p. 461-80.
5. Pochi PE, Shalita AR, Strauss JS, Webster SB, Cunliffe WJ, Katz HI, et al. Report of the consensus conference on acne classification. J Am Acad Dermatol 1991;24:495-500.
6. Liden S, Goransson K, Odsell L. Clinical evaluation in acne. Acta Dermato Venereol Suppl (Stockh) 1980;89:47-52.
7. Akman A, Durusoy C, Senturk M, Koc CK, Soyturk D, Alpossy E. Treatment of acne with intermittent and conventional isotretinoin: A randomised controlled multicenter study. Arch Dermatol Res 2007;299:467-73. (Pubitemid 350160055)
8. Culniffe WJ, van de Kerkhof PC, Caputo R, Cavicchini S, Cooper A, Fyrand OL, et al. Roaccutane treatment guidelines: results of an international survey. Dermatology 1997;194:351-7. (Pubitemid 27290560)
9. Peck GL, Olsen TG, Yoder FW, Downing DT, Pandya M, et al. Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. N Engl J Med 1979;300:329-33. (Pubitemid 9114884)
10. Farrell LN, Strauss JS, Stranieri AM. The treatment of severe cystic acne with 13-cis-retinoic acid. Evaluation of sebum production and the clinical response in a multiple-dose trial. J Am Acad Dermatol 1980;3:602-11. (Pubitemid 11214724)
11. Bellosta M, Vignini M, Miori L, Rabbiosi G. Low-dose isotretinoin in severe acne. Int J Tissue React 1987;9:443-6. (Pubitemid 18076981)
12. Goulden V, Clark SM, Cunliffe WJ. Post adolescent acne: A review of clinical features. Br J Dermatol 1997;136:66-70. (Pubitemid 27016177)
13. Hermes B, Praetel C, Henz BM. Medium dose isotretinoin for the treatment of acne. J Eur Acad Dermatol Venereol 1998;11:117-21. (Pubitemid 28445031)
14. Geissler SE, Michelsen S, Plewig G. Very low dose isotretinoin is effective in controlling seborrhoea. J Dtsch Dermatol Ges 2003;1:952-8. (Pubitemid 38101165)
15. Amichai B. Long term mini doses of isotretinoin in the treatment of relapsing acne. J Dermatol 2003;30:572. (Pubitemid 36950775)
16. Sardana K, Garg VK, Sehgal VN, Mahajan S, Bhushan P. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris. J Eur Acad Dermatol Venereol 2009;23:556-60.
17. Mandekou-Lefaki I, Delli F, Teknetzis A, Euthimiadou R, Karakatsanis G. Low dose schema of isotrinoin in acne vulgaris. Int J Clinical Pharmacol Res 2003;23:41-6. (Pubitemid 38282333)
18. Sardana K, Garg VK. Efficacy of low dose of isotretinoin in acne vulgaris. Indian J Dermatol Venereol Leprol 2010;77:7-13.
19. Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, et al. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne. J Am Acad Dermatol 2001;45:187-95. (Pubitemid 32729301)
20. Amichai B, Shemer A, Grunwald MH. Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol 2006;54:644-6.
21. Palmer RA, Sidhu S, Goodwin PG. 'Microdose' isotretinoin. Br J Dermatol 2000;143:205-6.
22. Sardana K, Sehgal VN. Retinoids: Fascinating up-and-coming scenario. J Dermatol 2003;30:355-80. (Pubitemid 36700374)
23. Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V, et al. Antibiotic-resistant acne: Lessons from Europe. Br J Dermatol 2003;148:467-78. (Pubitemid 36461325)
24. Rafiei R, Yaghoobi R. Azithromycin versus tetracycline in the treatment of acne vulgaris. J Dermatolog Treat 2006;17:217-21. (Pubitemid 44395547)